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Abstract
Background: Older people are commonly prescribed complex multi-drug regimens while also
experiencing declines in the cognitive and physical abilities required for medication management,
leading to increased risk of medication errors and need for assisted living. The purpose of this study
was to review published instruments designed to assess patients' capacity to self-administer
medications.
Methods:  Searches of Medline, EMBASE, CINAHL, PsycINFO, International Pharmaceutical
Abstracts, Health and Psychosocial Instruments, Google, and reference lists of identified
publications were conducted to identify English-language articles describing development and
validation of instruments designed to assess patients' capacity to self-administer medications.
Methodological quality of validation studies was rated independently against published criteria by
two reviewers and reliability and validity data were reviewed.
Results: Thirty-two instruments were identified, of which 14 met pre-defined inclusion criteria.
Instruments fell into two categories: those that used patients' own medications as the basis for
assessment and those that used a simulated medication regimen. The quality of validation studies
was generally low to moderate and few instruments were subjected to reliability testing. Most
instruments had some evidence of construct validity, through associations with tests of cognitive
function, health literacy, activities of daily living or measures of medication management or
adherence. Only one instrument had sensitivity and specificity data with respect to prediction of
medication-related outcomes such as adherence to therapy. Only three instruments had validity
data from more than one independent research group.
Conclusion: A number of performance-based instruments exist to assess patients' capacity to
manage their own medications. These may be useful for identifying physical and cognitive barriers
to successful medication management, but further studies are needed to determine whether they
are able to accurately and reliably predict medication outcomes.
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Background
Older people are commonly prescribed complex multi-
drug regimens, while also experiencing declines in the
cognitive and physical abilities required for medication
management [1,2]. Reduced competence in medication
self-administration is associated with higher risk of hospi-
talisation and requirement for assisted living [3-5].
Health professionals are not good at predicting patients'
ability to perform instrumental activity of daily living
(IADL), and impaired functional ability may not be
detected in routine clinical examinations [6]. More accu-
rate and reliable assessment methods are required [6].
Because high-level IADLs such as medication manage-
ment are dependent on cognitive abilities, global meas-
ures of cognitive function such as the mini-mental state
examination (MMSE) are sometimes used to predict func-
tional ability. However, these measures have demon-
strated inconsistent relationships with functional
performance and lack sensitivity in discriminating compe-
tent from incompetent individuals [2,7]. Most measures
of IADL performance rely on self-report or informant
report, which is a reasonable starting point since it is rela-
tively quick and easy [2,6]. However, a limitation is that
these measures are subjective and prone to bias [6]. Some
older people have difficulty evaluating their own compe-
tence or are reluctant to admit their inability to cope, lead-
ing to over-estimation of performance [6,8]. Family
members or caregivers may under- or over-estimate per-
formance, or may be unable to make a determination
because of a lack of opportunity to observe the patient
[6,8]. Furthermore, IADL scales are usually limited by reli-
ance on a single item to assess functional ability within
complex domains such as medication management and
lack of well-defined definitions for the skill required [8].
They also provide little information as to the cause of the
incapacity. Sometimes health professionals judge IADL
performance based on informal observation of the
patient, but these unstructured assessments are of
unproven efficiency for predicting performance, and the
results are usually unquantified and therefore not amena-
ble to comparison across or within individual patients [9].
There has been increasing interest in recent years in devel-
oping standardised, structured, performance-based meas-
ures that address the high-level IADLs using materials that
patients actually encounter in their daily lives [8,10]. Such
instruments can provide useful information not only in
terms of a score but also in terms of qualitative data relat-
ing to the individual's specific deficits.
The ideal assessment instrument should be objective,
quantitative, reliable, readily administered with minimal
training, easily and immediately scorable, brief, small and
portable and non-threatening to the subject. It should
assess both cognitive and physical abilities, [2,11] and
demonstrate clinical utility by providing information to
guide planning, application and/or monitoring of medi-
cation management interventions. It should have better
(or more reliable) predictive validity than self-report,
informant report and non-standardised assessment, and
demonstrate sensitivity to changes in function over time
as cognitive or physical function deteriorates.
A recent review identified 16 instruments designed to
assess patients' capacity to manage medications [12].
However the review was limited by the omission of sev-
eral instruments and validation studies, and the absence
of critical appraisal of the methodological quality of vali-
dation studies. The objective of our study was to critically
review the reliability and validity of published instru-
ments designed to assess patients' capacity to self-admin-
ister medications and identify those that may be suitable
for use in clinical practice or research.
Methods
Search strategy
A search of Medline (1966–2007), EMBASE (1980–
2007), CINAHL (1982–2007), PsycINFO (1967–2007)
International Pharmaceutical Abstracts (IPA; 1970–2007)
and Health and Psychosocial Instruments (1985–2007)
was conducted using the following terms: self administra-
tion, medication, medicine or drug, and ability, capacity,
competence, skill or geriatric assessment (limited to Eng-
lish language). Relevant reference texts [13-15], and Inter-
net sites [16,17] were reviewed, and bibliographies of
identified papers were screened.
Inclusion and exclusion criteria
To be included, instruments had to meet the following cri-
teria:
1. Designed to assess cognitive and physical ability to
manage medications;
2. Utilised standardised, structured, quantitative, direct
observation of patients' medication management per-
formance;
3. Described in adequate detail to enable test to be repli-
cated (all items and instructions published or able to be
obtained from authors);
4. At least one published report of psychometric evalua-
tion of instrument performance.
Instruments were excluded if they relied on self-report or
informant-report or included non-medication domains
(e.g. financial management, cooking) without providing
separate psychometric data on the medication domain.BMC Geriatrics 2009, 9:27 http://www.biomedcentral.com/1471-2318/9/27
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When studies appeared to fulfil the inclusion criteria, or in
cases of doubt, full-text copies were obtained. The litera-
ture search was conducted by one author (RAE), but
before any instrument was excluded it was independently
reviewed against the inclusion criteria by the second
author.
To ensure that we had all available psychometric data, a
search of Medline, EMBASE, IPA and Google was per-
formed using the full and abbreviated name of each
instrument (May 2008), and the authors of studies that
described development of a novel tool were contacted by
email to request unpublished data, tool revisions and
instructions for use. Information on each instrument was
compiled using a standard template that included: instru-
ment purpose, components of assessment, administration
and scoring procedures, time to administer, validation
samples, reliability and validity data.
Methodological quality of validation studies
Validation studies were reviewed independently by both
authors and methodological quality was rated using crite-
ria based on the Standards for Reporting of Diagnostic
Accuracy [see Additional file 1] [18]. In cases of disagree-
ment studies were discussed and consensus reached.
Instrument validity
Because there is no accepted 'gold standard' measure of
medication management ability against which criterion
validity can be judged [8,10], we reviewed content valid-
ity, construct validity, and responsiveness to change [19].
Content validity was judged through a consensus process
involving both authors, by determining whether instru-
ments assessed each of the main skill-areas necessary for
medication management: 1) identify medications (e.g. by
reading the label or recognising packaging), 2) access
medications from packaging, 3) comprehend and explain
or demonstrate medication instructions, 4) recall infor-
mation, and 5) administer medications [1,20]. Construct
validity was judged by reviewing the strength of one or
more of the following: association between subjects' per-
formance on the instrument and tests of related constructs
(e.g. medication adherence, IADL performance, cognitive
function, health literacy), convergent validity (where per-
formance on the instrument was compared with another
measure of medication management ability such as a car-
ers' judgement or performance on a second medication
management instrument), discriminative or 'extreme
groups' validity (where the instrument was administered
to a group of subjects known to have problems with med-
ication management or cognitive performance and nor-
mal controls), or comparison of instrument performance
with subjects' self-reported medication management or
place of residence (i.e. independent living versus sup-
ported care).
Based on instruments' reliability, validity and quality of
validation studies, together with ease and practicality of
use (e.g. administration time), we selected instruments
that in our opinion showed most potential for use in clin-
ical practice.
Results
Forty-nine published reports describing development
and/or application of 32 instruments were identified.
Eighteen did not meet the inclusion criteria (Table 1) [21-
38].
The 14 instruments included in the review fell into two
broad categories: those that used the patients' own medi-
cations as the basis for assessment [39-41], and those that
used a simulated medication regimen [42-52]. Two tools
used a simulated regimen plus assessment of knowledge
of the patients' own medications [42,44]. A description of
the included instruments is provided in Additional file
2[53,54].
Content validity
The extent to which instruments assessed medication
management skills was variable [see Additional file 3].
The theoretical framework or method used to select or
develop test items was not reported in most cases. All
instruments apart from MedMaIDE [41] required the
patient to identify one or more medication either by read-
ing a label or some other method. All instruments
required the patient to open at least one type of medica-
tion packaging, and all except MAI [42] and MMPT [52]
required the patient to remove a dose. All instruments
except MMPT [52] required the patient to comprehend
and either explain or set-out at least one medication. Abil-
ity to administer medication (e.g. swallow an oral dose)
was assessed by two tools (MedMaIDE, PA) [41,44]. Six
instruments assessed ability to recall information [40-
42,44,46,49].
Administration time
Most instruments were reported to take between 5 and 15
minutes to administer [see Additional file 2]. Instruments
that included an assessment of medication knowledge in
addition to the medication-taking task required more
time (15–30 minutes) [40-42,44,47]. Administration
time may be longer in patients with cognitive impair-
ment, and more variable for instruments that use patients'
own medications because of the variable number of med-
ications [55]. Five instruments had a time limit or timed
component [42,45,49-51].
Quality of validation studies
The quality of validation studies was generally low to
moderate [see Additional file 4]. Most instruments were
tested in relatively small, homogenous samples recruitedBMC Geriatrics 2009, 9:27 http://www.biomedcentral.com/1471-2318/9/27
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from a single setting. Some studies specifically excluded
cognitively impaired individuals [42,45,49,50,55], and
only one instrument was tested in a representative sample
of older people [52]. For 10 instruments the person
administering the assessment was not blinded to results of
the reference standard and other validation tests (e.g. cog-
nitive function, IADL scores), or this information was not
provided [40-45,47,50-52]. In other cases, the rater was
blinded to some, but usually not all, patient data
[39,46,48,49,56]. Most studies did not adequately
describe reasons for patient exclusion or their characteris-
tics relative to the study subjects [40-43,45-49,51], or
whether study subjects were currently managing their own
medications [42-44,46-51], making generalisation of
findings difficult and introducing potential spectrum bias
[13,18,57]. In six studies the reference standard was not
applied to all subjects [9,44,45,47-49]. Only one valida-
tion study (MedMaIDE) reported sensitivity and specifi-
city with respect to its ability to predict a medication-
related outcome [41].
Only three instruments were evaluated in multiple popu-
lations by more than one research group (MMEI, DRUGS,
MMAA) [see Additional file 4]. The MMAA has been most
widely used, but all except one study involved subjects
with schizophrenia or other mental health disorders, lim-
iting generalisability.
In many cases, inadequate information was provided to
allow the test to be replicated, so contact with the devel-
opers was necessary. Some instrument developers have
made modifications after publishing the instrument,
seemingly without further validation (e.g. MMAA, MMT-
R).
Reliability
Few instruments were subjected to reliability testing [see
Additional file 4]. Only three (DRUGS, MedMaIDE,
MMT) have inter-rater reliability data available
[39,41,47], and for two of these (DRUGS, MMT) the
methods by which the data was obtained was not ade-
quately described [39,47]. Three instruments have test-
retest reliability data (DRUGS, MedMaIDE, MMAA)
[39,41,49]. Internal consistency was reported for four
instruments (HMS, MedMaIDE, MMT, MM Test)
Table 1: Excluded medication management assessment instruments
Instrument Author Reason for exclusion
Assisted Living Facilities Medication Assessment Meade 2001 [21] • No psychometric evaluation
Dexterity Test Begley 1997 [22] • Insufficient detail*
• No psychometric evaluation
• Assessment of physical ability only
Everyday Cognitive Battery Allaire 1999 [23] • Multi-domain tool†
• Insufficient detail*
• Assessment of cognitive ability only
Everyday Problems Test Willis 1996 [24] • Multi-domain tool†
• Insufficient detail*
• Assessment of cognitive ability only
Functional Limitations Assessment Hurd 1986 [25] • No psychometric evaluation
Medication Management Test Corrigan 1994 [26] • Insufficient detail*
Medication Regimen Adherence Capacity Test Fitten 1995 [27] • Psychometric evaluation of only part of the test
Observed Tasks of Daily Living (OTDL) Diehl 1995 [28] • Multi-domain tool†
Occupational Therapy Assessment Scale (OTAS) Fairbrother 1997 [29] • Multi-domain tool†
• Insufficient detail*
Occupational Therapy Assessment of Performance and 
Support (OTAPS)
Nadler 1993 [30] • Multi-domain tool†
• Insufficient detail*
Reading/Comprehension and Task Performance Tool Bailey 1995 [31] • Insufficient detail*
Regimen Comprehension Scale Yamada 2001 [32] • Assessment of cognitive ability only
• Insufficient detail*
Structured Assessment of Independent Living Skills (SAILS) Mahurin 1991 [33] • Multi-domain tool†
Self-Administration of Medication tool Manias 2006 [34] • No standardised structured observation of task 
performance
Self-Medication Risk Assessment Instrument Fuller 2005 [35] • No standardised structured observation of task 
performance
Structured Home Interview Sedgeworth 1990 [36] • Insufficient detail*
Timed Activities of Daily Living (TIADL) Owsley 2002 [37] • Multi-domain tool†
• Assessment of cognitive ability only
Virtual Reality Apartment Medication Management Assessment Kurtz 2007 [38] • Assessment of cognitive ability only
* insufficient detail to enable tool to be replicated
† multi-domain tool with no separate psychometric evaluation of the medication componentBMC Geriatrics 2009, 9:27 http://www.biomedcentral.com/1471-2318/9/27
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[41,46,47,50]. No instrument has had its reliability con-
firmed independently by a second research group.
Construct validity
Cognitive function
The association between medication management per-
formance and measures of cognitive function was investi-
gated for 11 instruments, and an association was found
with 10 of these [see Additional file 4]. The association in
most cases was moderate (correlation coefficient 0.4–0.6)
(DRUGS, MedTake, MedMaIDE, MMAA, MAT) [39-
41,49,51,58-60]. For one instrument (MM Test), which
was originally developed as a screening tool for dementia,
the association was stronger (r = 0.66, p < 0.001) [46]. For
four instruments no correlation coefficient was provided
(MMEI, MMT, MMT-R, HMS) [43,47,48,50,61-63]. Lack
of association with SM Task may have been due to the
small homogenous sample (n = 20, MMSE >25/30) [45].
Health literacy
The association between medication management per-
formance and validated measures of health literacy was
reported for two instruments [see Additional file 4]. Med-
Take scores were associated with performance on the
Rapid Estimate of Adult Literacy in Medicine (REALM) (r
= 0.344; p < 0.01) [64]. In multiple regression analysis,
REALM was the strongest predictor of MedTake score,
accounting for 27% of variance. In another study, DRUGS
scores increased with increasing literacy (p = 0.001) [65].
Activities of daily living
Self-reported basic ADL performance was included in val-
idation studies for three instruments [see Additional file
4] [39,41,61], and a positive association with medication
management was found in only one (MMEI) [61]. This is
not surprising since medication management is a high-
level ADL and participants in most studies were relatively
high functioning. In the study where an association was
reported, 46% of subjects were dependent for at least one
basic ADL [61].
Self-reported IADL performance was assessed in studies
with five instruments, and an association was reported
with three of these (HMS, MAT, MMT-R) [see Additional
file 4] [48,50,51]. There was no association between
DRUGS scores and self-reported IADL performance [39],
while in the MedMaIDE validation study IADL data was
collected but not reported [41]. Given the limitations of
self-reported functioning, observed IADL performance
would be a more valid comparator [6,8]. This was availa-
ble for two instruments, and a moderate association was
found in both cases. The MMAA instrument was associ-
ated with scores on the Direct Assessment of Functional
Status instrument, a multi-domain functional perform-
ance measure (r = 0.51, p < 0.001) [49]. The MAT instru-
ment was associated with performance on the food
preparation item of the Naturalistic Action Test (r = 0.46,
p < 0.001) [51].
Medication adherence
Self-reported adherence was assessed in studies with four
instruments [see Additional file 4]. Although there was an
association with two items on the MAI, overall test per-
formance was not reported [42]. There was no association
with instrument performance in a study using DRUGS
and MMAA [55], and another using MMT [47]. There was
an association between MMAA total-score and self-
reported adherence (r = 0.37, p < 0.01) in a subgroup
analysis of independent-living older patients with mental
illness, but validity of this association is questionable
because there was no association with pill count adher-
ence in the same study [66].
Objective measures (e.g. pill count, medication refills)
may provide a more accurate estimate of medication
adherence, and these were included in studies with five
instruments [see Additional file 4]. The primary valida-
tion study for the MMAA included a subgroup analysis of
22 subjects with schizophrenia for whom 12 months of
medication refill data was available, and reported 67%
agreement (p < 0.001) in classification of patients into
adherent versus nonadherent using medication refill and
MMAA pill-count score (not MMAA total score) [49].
However >50% of subjects resided in supported care and
may not have been responsible for managing their own
medications. In another study, there was no association
between MMAA total score and pill count adherence in
older patients with mental illness, but in a post-hoc sub-
group analysis of subjects who lived independently there
was a weak association with the MMAA pills-under score
(r = 0.3, p < 0.05) [66]. There was a moderate association
between 30-day pill count adherence and MedMaIDE
scores (r = -0.52, p-value not reported) [41]; in a regres-
sion analysis, 27% of the variance in pill count adherence
was accounted for by the MedMaIDE score (p < 0.001),
and using a score of >1 as the cut-off, sensitivity was 68%
and specificity 83% [41]. No association was found
between adherence and instrument scores in studies using
the MMEI, SM Task and PA [45,62,67], but in two studies
adherence was assessed for only 16 and 14 subjects
respectively [45,62], while interpretation of the third
study is limited by poor description of the methodology
[67].
Other measures of medication management ability
The PA instrument was compared with success in an inpa-
tient self-medication program or self-medication at home.
Although the authors reported 69% predictive accuracy,
neither the cut-score for the instrument nor the criteria for
successful self-medication was reported [44]. Also, treat-BMC Geriatrics 2009, 9:27 http://www.biomedcentral.com/1471-2318/9/27
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ing physicians' and nurses' opinions had similar predic-
tive accuracy without using the instrument (62% and 58%
respectively) [44]. There was a moderate correlation
between MMAA and DRUGS scores in 52 independently
living patients (r = 0.56, p = 0.000) [55].
Discriminative (extreme groups) validity
In a study where MMAA performance in older schizo-
phrenic patients and normal controls was compared,
patients scored significantly lower than controls [49].
When MMT-R performance in HIV-positive subjects with
and without cognitive impairment was compared, those
with impaired cognition were more likely to fail [48].
Similarly, when Fulmer et al split their sample of older
people into normal cognitive status and cognitively
impaired, poor scores on the MM Test were obtained sig-
nificantly more often in subjects with cognitive impair-
ment [9]. In cross-sectional studies both DRUGS and MAT
scores were significantly lower in assisted living subjects
compared with independent living subjects [39,51],
although it is possible that this finding is confounded by
lack of medication familiarity and recent practice among
assisted living subjects.
Independent medication management
The relationship between medication management task
performance and whether or not patients were independ-
ently managing their medications at home was reported
for four instruments (DRUGS, MMEI, MMTest, MMPT)
[39,43,46,52]. Although performance was related to self-
reported or caregiver-reported medication management
in all four studies, again this could be confounded by lack
of medication familiarity or practice for those not manag-
ing their own medications.
Place of residence
In a prospective study, baseline DRUGS scores predicted
residence in assisted living at 6 months but not 12 months
[56]. Change in DRUGS scores between baseline and 12
months was associated with residence in assisted living at
12 months [56].
Responsiveness to change
Only two instruments were evaluated in longitudinal
studies. The DRUGS instrument demonstrated respon-
siveness to changes in cognitive function over 12 months
in 52 highly functioning older people [56], and over six
months in an interim analysis of an unpublished study
with a more diverse group of 58 older people [68]. MMAA
scores increased following a 12 week group medication
skills training program in an uncontrolled pilot study
involving 16 patients with bipolar disorder [69].
Head-to-head comparisons
Only one study has been published in which two medica-
tion management instruments (MMAA and DRUGS) were
administered to the same population [55]. As noted
above, there was an association between the two instru-
ments' scores, suggesting they were measuring the same
construct. Patients performed better on DRUGS than
MMAA, with 87% and 18% attaining the maximum pos-
sible score, and mean scores of 92% and 78% respectively
[55]. Better performance on the DRUGS instrument may
be partially explained by medication familiarity since
DRUGS uses the patients' own medications. It may also be
a result of the different scoring systems. Six patients (11%)
refused to take the DRUGS test, usually because they did
not want to bring their medications to the clinic. In con-
trast only three patients refused to take the MMAA test:
two felt they would be unable to do it (both had MMSE
20/30) and one cited 'lack of time' [55].
Discussion
There have been many attempts to develop a standard-
ised, objective, quantitative measure of patients' ability to
manage their own medications, but no published instru-
ment currently has sufficient evidence of reliability and
validity to allow it to be recommended for routine use in
clinical practice to predict outcomes such as medication
adherence or errors. Most instruments have had limited
evaluation of reliability, and although most have demon-
strated an association with at least one related construct
there is limited evidence of ability to predict successful
independent medication management in the real world. A
wide variety of reference standards and comparators has
been used for validity assessment, making it difficult to
compare instruments. All validation studies had method-
ological shortcomings and most were conducted in small
homogenous populations, which can lead to overestima-
tion of instrument validity [13,70]. Therefore the data for
most instruments needs to be regarded as preliminary,
until confirmed in larger, well-designed studies. The pos-
sibility of publication bias leading to over-estimation of
instrument validity also needs to be considered.
Based on current evidence, the instruments that in our
opinion show most promise and may warrant further
investigation are: DRUGS, MAT, MedMaIDE, MMAA, MM
Test and MMEI.
DRUGS [39] and MedMaIDE [41], which both use
patients' own medications, are the only instruments with
evidence of both inter-rater and test-retest reliability,
although this needs to be confirmed by researchers other
than the instruments' developers. The MedMaIDE instru-
ment demonstrated construct validity through moderate
correlations with pill-count medication adherence and
cognitive function, albeit in a single small study. A disad-BMC Geriatrics 2009, 9:27 http://www.biomedcentral.com/1471-2318/9/27
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vantage is that it requires 30 minutes for administration.
The DRUGS instrument demonstrated construct validity
through its associations with cognitive function, health
literacy, independent medication management and
MMAA performance. It has also been shown to be respon-
sive to change, and has the advantage that it has been val-
idated in several patient groups by three different research
groups. It requires up to 15 minutes for administration.
The MAT [51] and MMAA [49] both require patients to
set-out 24 hours of a simulated medication regimen. They
take around 15 minutes to administer, but the MMAA
requires an additional 45–60 minute delay between
explaining the regimen to the patient and task comple-
tion. Validity of both instruments is supported by moder-
ate correlations with cognitive function and observed
IADL performance. MAT performance has also been asso-
ciated with level of supported care, and MMAA perform-
ance has been associated with DRUGS scores. MAT has no
reliability data, and has only been validated in one small
study. A strength of the MMAA is that it has been validated
by multiple research groups in large numbers of patients,
although mostly patients with mental health disorders.
Despite its widespread use, it has never been subjected to
inter-rater reliability testing. MAT uses more medications
but has a simpler scoring method that incorporates task
completion time, which may improve discriminative
validity [11].
MM Test [46] and MMEI [43] also use simulated medica-
tions but have the advantage of being faster to administer,
requiring approximately 5 minutes. MM Test is strongly
associated with cognitive function and moderately associ-
ated with independent medication management. It has
good internal consistency, but inter-rater and test-retest
reliability is unknown. MMEI has shown weaker associa-
tion with these two variables but has been evaluated by
three research groups. It has not been subjected to reliabil-
ity testing.
Although further research is needed before any of these
instruments could be used to reliably predict medication
outcomes, they could be used to qualitatively identify bar-
riers to successful medication management. Used in this
way they could assist health professionals to identify indi-
vidual patients' need for education, regimen simplifica-
tion, medication assistance or medication aids [44]. In
this context, the DRUGS, MedMaIDE, MedTake, MAI,
MMEI and PA instruments may provide the most infor-
mation about physical barriers and medication knowl-
edge, while the MM Test, MMAA and MAT instruments
may provide the best assessment of medication-related
cognitive abilities. A limitation of most instruments in the
assessment of physical barriers is that they assess ability to
access medications from vials only, whilst increasingly
medications are supplied in foil or blister-packs which can
also be difficult for patients to manage [1], and no instru-
ment assesses ability to self-administer complex dose-
forms such as inhalers and eye drops.
Our choice of instruments warranting further study differs
from recommendations made in an earlier review by Far-
ris and Phillips [12]. Consistent with our recommenda-
tions they selected DRUGS, MedMaIDE and MMAA,
however they also selected MMPT and HMS. We did not
recommend MMPT because, although it is a brief test, it
assesses a limited range of medication management skills
and it has limited construct validity data and no reliability
data.
The HMS also has limited construct validity and reliability
data and seems to offer no advantage over similar, better-
validated simulated medication regimen instruments
such as MMAA or MAT.
Although the choice of instruments is somewhat subjec-
tive, a strength of our review compared with that of Farris
and Phillips is that methodological quality of validation
studies was formally assessed and, together with psycho-
metric data, considered in the selection process. We also
considered instruments' applicability in all settings, not
just primary care. A limitation of both reviews is that
searches were limited to English language publications,
possibly leading to some instruments being overlooked.
Farris and Phillips suggested that instruments using
patient's own medications may be preferable due to
greater test authenticity and ability to assess patients'
medication knowledge [12]. These instruments also have
the advantage of not requiring special materials or props.
However they also have potential disadvantages: patients'
own medications need to be available, which may be
problematic in inpatient and clinic settings, and patients
may be reluctant to provide their medications for the test
[55]. These instruments may be best suited to situations
where assessment occurs in patients' homes or as part of a
'brown bag medication review'. Instruments using simu-
lated medications provide a higher level of test standardi-
sation, allowing comparisons to be made between
patients and within patients over time. They may be suited
to settings where patients' own medications are unavaila-
ble or medications are being newly commenced, such as
clinics or hospital wards. Because these tests use a medica-
tion regimen that is not familiar to the patient, they are
able to assess capacity to manage new medications (e.g.
after discharge from hospital). To avoid bias due to med-
ication familiarity, it may be preferable that simulated reg-
imens contain mock medications (e.g. as in MMAA),
rather than real medications.BMC Geriatrics 2009, 9:27 http://www.biomedcentral.com/1471-2318/9/27
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No study has reported on the acceptability of medication
management assessment instruments to patients. Admin-
istration of these instruments in clinical practice could
potentially be stressful for frail elderly patients, especially
if they believe that poor performance may lead to loss of
independence (e.g. placement in residential care). It is
possible that instruments using patients' own medica-
tions may be less threatening compared to unfamiliar
simulated regimens, but this has not been studied and is
not supported by a finding that fewer patients declined to
take the MMAA test than the DRUGS test in the only study
that has compared two instruments [55].
Instrument development is ongoing. We are aware of
three additional instruments that were not included in
this review, all using simulated medications. Two had
only been published in abstract or thesis form [71,72],
while the third was published after this review was com-
pleted and assessed cognitive medication management
abilities only [73]. There is a need for further research to
confirm the reliability and validity of published standard-
ised medication management assessment instruments.
The quality of validation studies needs to be improved, for
example by blinding testers to results of reference stand-
ard assessments. When medication adherence is used for
instrument validation, objective adherence measures
should be used, and only patients who are responsible for
managing their own medications included. However, it
may be unrealistic to expect any of the current instru-
ments to predict medication adherence with a high level
of accuracy. Since most instruments assess only the cogni-
tive and physical abilities required to manage medica-
tions, their results reflect subjects' capacity to accomplish
the tasks, and performance in real life may not fulfil the
potential indicated by capacity [6,10,46]. A range of addi-
tional factors contribute to whether or not a patient will
adhere to a medication regimen, including: motivation,
belief that the therapy is necessary and effective, self-effi-
cacy, relationship with healthcare providers, lifestyle and
cultural factors and financial capacity [8,10,20]. The Med-
MaIDE instrument, which had a moderate association
with pill-count adherence included items related to
accessing ongoing medication supplies, in addition to
physical and cognitive abilities [41]. Inclusion of items
addressing additional adherence-related factors could
potentially increase predictive accuracy. Novel validation
methods may be required in future studies, due to the lack
of a 'gold standard' for medication management ability.
For example, the instrument could be administered to
hospital patients entering an inpatient self-administration
of medication program, allowing performance on the
instrument to be compared with performance on the pro-
gram.
Conclusion
A number of performance-based instruments exist to
assess older patients' ability to manage their own medica-
tions. These instruments may be useful for identifying
physical and cognitive barriers to successful medication
management, but further studies are needed to determine
whether they are able to reliably predict medication out-
comes such as adherence or errors.
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